Close mobile menu×
Close mobile menu

Michael T. Yin, MD

Board Certifications: 
Infectious Disease
Accepting New Patients

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-8039

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Infectious Disease

Clinical Expertise

  • HIV Infection
  • HIV Medicine
  • Infectious Disease
  • HIV/AIDS

Specialties

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

2011                            Irving Scholars Award

2015                            Harold and Golden Lamport Award for Excellence in Clinical Science Research

2017                            Ewig Clinical Scholar Award for Clinical Education

About Michael Yin

Dr. Yin is an Associate Professor of Medicine in the Division of Infectious Diseases.

Academic Titles

  • Associate Professor of Medicine at CUMC

Administrative Positions

  • Associate Fellowship Program Director

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 2-242
New York, New York 10032
Phone:
(212) 305-8039
Fax:
(212) 305-1754
Primary

Research

Dr. Yin’s research is focused on the optimization of HIV treatment and care, especially through prevention of non-AIDS complications of HIV infection and antiretroviral therapy (ART). He has examined the epidemiology and pathogenic mechanisms of HIV associated bone loss in perinatally-infected children, adolescents, and postmenopausal women utilizing novel imaging techniques and translational bone cell assays to investigate dysregulation of bone metabolism associated with HIV infection and ART. Currently, he is investigating the impact of oral immune activation on periodontal health and alveolar bone loss in HIV-infected women. Dr. Yin has extensive interdisciplinary research experience in HIV. He is an active investigator in AIDS Clinical Trials Group (ACTG) and the Women’s Interagency HIV Study (WIHS). Dr. Yin is a Co-Director of the Bio-behavioral Core, for the HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University. Dr. Yin also is an Associate Program Director for the Fellowship Training Program in Infectious Diseases at CUMC.

Research Interests

  • HIV therapy and metabolic complications

Grants

IMPACT OF COMBINED USE OF DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION AND TENOFOVIR PREEXPOSURE PROPHYLAXIS ON BONE HEALTH (DEPO-PREP) (Federal Gov)

May 17 2017 - Mar 31 2022

ORAL IMMUNE ACTIVATION AND ALVEOLAR BONE LOSS IN HIV-INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Apr 1 2017 - Jan 31 2022

PRECISION IN SYMPTOM SELF-MANAGEMENT (PRISSM) CENTER (Federal Gov)

Aug 16 2016 - May 31 2021

NEW APPROACHES TO THE EVALUATION AND TREATMENT OF ACROMEGALY (Federal Gov)

May 1 2017 - Apr 30 2021

COLUMBIA PARTNERSHIP FOR PREVENTION AND CONTROL OF HIV/AIDS CLINICAL TRIALS UNIT (COLUMBIA PARTNERSHIP CTU) (Federal Gov)

Dec 1 2013 - Nov 30 2020

OPTIMIZING CLINICAL USE OF POLYMYXIN B: TEACHING OLD DRUG TO TREAT SUPERBUGS (Federal Gov)

Apr 1 2017 - May 31 2020

A PHASE 3, MULTI-CENTER, RANDOMIZED, OPEN-LABEL STUDY OF CARBAVANCE (MEROPENEM/RPX7009) VERSUS BEST AVAILABLE THERAPY IN SUBJECTS WITH SELECTED SERIOUS INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (P&S Industry Clinical Trial)

Oct 29 2014 - Oct 29 2019

BONE HEALTH IN PERINATALLY HIV-INFECTED SOUTH AFRICAN CHILDREN ON ANTIRETROVIRALS (Federal Gov)

Jul 16 2012 - Jun 30 2019

A MULTI-CENTER, RETROSPECTIVE STUDY OF CASES OF SERIOUS INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (P&S Industry Clinical Trial)

Jun 23 2014 - Jun 23 2019

BIOLOGICAL AGING IN OLDER HIV-INFECTED AFRICAN AMERICANS (Federal Gov)

Sep 1 2017 - May 31 2019

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO COMPARE THE EFFICACY AND SAFETY OF CADAZOLID VERSUS VANCOMYCIN IN SUBJECTS WITH CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) (P&S Industry Clinical Trial)

Apr 21 2014 - Apr 21 2019

HIV CENTER FOR CLINICAL AND BEHAVIORAL STUDIES (Federal Gov)

Mar 23 2018 - Jan 31 2019

A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE VERSUS ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN HIV-1 POSITIVE, ADULTS (P&S Industry Clinical Trial)

Sep 3 2013 - Sep 3 2018

HIV AND THE MENOPAUSAL TRANSITION: EFFECTS ON MUSCULOSKELETAL HEALTH (Federal Gov)

May 1 2011 - Apr 30 2018

BONE AND RENAL OUTCOMES IN VIROLOGICALLY STABLE SOUTH AFRICAN HIV-INFECTED ADOLESCENTS SWITCHING TO TENOFOVIR (TDF)-CONTAINING ANTIRETROVIRAL THERAPY. (Private)

Dec 15 2016 - Dec 16 2017

OSTEOPOROSIS IN HIV INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Jul 1 2010 - Jun 30 2016

TAMIFLU-ROCHE: A MULTICENTER, STUDY OF THE SAFETY OF OSELTAMIVIR ADMINSTERED INTRAVENOUSLY FOR THE TREATMENT OF INFLUENZ (P&S Industry Clinical Trial)

Sep 30 2010 - Sep 30 2015

AGING AND FRACTURE RISK AMONG HIV-INFECTED AND HIV-UNINFECTED MEN (Federal Gov)

Sep 1 2011 - Aug 31 2015

GS-US-236-0103 (P&S Industry Clinical Trial)

Jul 14 2010 - Jul 14 2015

PHASE 3,OPEN-LABEL,SINGLE-ARM TRIAL TO EVALUATE THE SAFETY, TOLERABILITY & IMMUNOGENICITY OF 3 DOSES OF 13VPNC IN HIV (P&S Industry Clinical Trial)

Mar 10 2010 - Mar 10 2015

A QUALITATIVE STUDY OF HEPATITIS C VIRUS TREATMENT BARRIERS AMONG HCV/HIV CO-INFECTED PATIENTS AND THEIR PROVIDERS IN THE ERA OF TRANSITION TO INTERFERON-SPARING REGIMENS (Private)

Nov 26 2013 - Nov 25 2014

ACTG LEADERSHIP AND OPERATIONS CENTER SUPPLEMENTAL FUNDING (Federal Gov)

Jun 1 2012 - Dec 31 2013

ACTG LEADERSHIP AND OPERATIONS CENTER SUPPLEMENTAL FUNDING (Federal Gov)

Jun 1 2012 - Dec 31 2013

HVTN 505CORE LEADERSHIP ROLE (Federal Gov)

Jun 1 2009 - Dec 31 2013

HIV VACCINE TRIALS UNIT - HVTN 505 (Federal Gov)

Jun 1 2009 - Aug 31 2013

CO-CHAIR ACTG PROTOCOL A5280 (Federal Gov)

Jun 1 2012 - Aug 15 2013

SOLID ORGAN TRANSPLANTATION IN HIV-MULTI-SITE STUDY (Federal Gov)

Sep 26 2008 - Aug 31 2012

CO-CHAIR ACTG PROTOCOL A5280 (Federal Gov)

Jun 1 2011 - May 31 2012

MK-0518/RALTEGRAVIR (P&S Industry Clinical Trial)

Feb 25 2009 - Dec 31 2011

GS-US-183-0144, A MULTICENTER, RANDOMIZED, DOUBLE-BLIND,DOUBLE-DUMMY,PHASE 3 STUDY OF THE SAFETY AND EFFICACY OF RITONAV (P&S Industry Clinical Trial)

Mar 25 2009 - Jun 30 2011

Selected Publications

Yin MT, McMahon D, Ferris D, Zhang C, Shu A, Staron R, Colon I, Laurence J, Dobkin J, Hammer S, Shane E “Low bone mass and high bone turnover in postmenopausal HIV-infected women” Journal of Clinical Endocrinology and Metabolism 2010; 95(2):620-9 PMID: 19965927  PMCID:PMC2840861

Yin MT, Lu D, Cremers S, Tien PC, Cohen MH, Shi Q, Shane E, Golub ET, Anastos K, “Short term bone loss in HIV-infected premenopausal women” Journal of Acquired Immune Deficiency Syndrome, 2010; 53(2): 202-8 PMID: 19890216  PMCID:PMC2813405  NIHMSID:NIHMS153877

Yin MT, Shi Q, Hoover DR, Anastos KA, Sharma A, Young M, Levine A, Cohen M, Shane E, Golub ET, Tien PC, “Fracture incidence in HIV infected women: results from the Women’s HIV Interagency Study” AIDS 2010; 24(17):2679-86 PMID:20859192  PMCID:PMC3108019

Yin MT, Modarresi R, Shane E, Santiago F, Ferris DC, McMahon DJ, Cremers S, Laurence J. Effects of HIV infection and antiretroviral therapy with ritonavir on bone turnover and osteoclast induction. Osteoporosis International 2011, 22(5): 1459-68. PMID: 20683705 PMCID: PMC3118504

Yin MT, Zhang CA, McMahon DJ, Ferris DC, Irani D, Colon I, Cermers S, Shane E “Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study” Journal of Clinical Endocrinology and Metabolism 2012 97(2): 554-62 PMID 22090266 PMCID: PMC3275353

Kubin CJ, Ellman T, Phadke V, Haynes LJ, Calfee DP, Yin MT. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. Journal of Infection 2012; 65(1) 80-7. PMID: 22326553.

Yin MT, Kendall MA, Wu X, Tassiopoulos K, Hochberg M, Huang JS, Glesby MJ, Bolivar H, McComsey GA, “Fractures after antiretroviral initiation: An analysis of the ACTG longitudinal linked randomized trial (ALLRT) study,” AIDS 2012 26(17):2175-84. PMID: 22951635 PMCID: PMC3652631

Yin MT, Lund E, Shah J, Zhang CA, Foca M, Neu N, Nishiyama KK, Zhou B, Guo E, Nelson J, Bell D, Shane E, Arpadi SA. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life, AIDS 2013 28(3): 345-54. PMID: 24072196 PMCID: PMC4019223

Wright K, Young PC, Brickman C, Sam T, Pereira M, Badjatia N, Connolly ES, Yin MT. Rates and determinants of ventriculostomy-related infections (VRI) during a hospital transition to use of antibiotic-coated external ventricular drains. Neurosurgical Focus 2013 34(5) E12. PMID: 23634916

Shiau S, Lund EC, Arpadi S, Yin MT, Incident fractures in HIV-infected individuals: a systematic review and meta-analysis, AIDS 2013; 27(12):1949-1957. PMID: 24126140

Dong HV, Cortes YI, Shiau S, Yin MT. Osteoporosis and fractures in HIV/HCV-coinfection: a systemic review and meta-analysis, AIDS, 2014 28(14):2119-31. PMID: 24977441

Sharma A, Shi Q, Hoover DR, Anastos K, Tien PC, Young M, Cohen MH, Golub ET, Gustafson D, Yin MT. Increased fracture incidence in middle-aged HIV-infected and uninfected women: updated results from the Women’s Interagency HIV Study. Journal of Acquired Immunodeficieny Syndrome 2015, 70(1):54-61. PMID 26322667

Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Tenorio A, Melbourne K, Napoli A, Ribaudo HJ, Yin MT. High-dose vitamin D and calcium attenuates bone loss with antiretroviral therapy initiation: a prospective, randomized placebo-controlled trial for bone health in HIV-infected individuals. Annals of Internal Medicine 2015, 162(12):815-824. PMID: 26075752 PMCID: PMC4608553

Gordon CL, Tokarz R, Briese T, Lipkin I, Jain K, Whittier S, Connolly ES, Yin MT. Evaluation of a multiplex polymerase chain reaction for early diagnosis of ventriculostomy-related infections. Journal of Neurosurgery 2015, 123(6):1586-92. PMID: 26023998

Manavalan JS, Apradi S, Tharmarajah S, Shah J, Zhang CA, Foca M, Neu N, Bell DL, Nishiyama K, Kousteni S, Yin MT. Abnormal bone acquisition with early-life HIV infection: role of immune activation and senescent osteogenic precursors. Journal of Bone and Mineral Research 2016, 31(11):1988-1996. PMID: 27283956

Yin MT, Shiau S, Rimland D, Gibert CL, Bedimo RJ, Rodriguez-Barradas MC, Harwood KE, Ascheim J, Justice AC, Womack JA. “Fracture prediction with modified FRAX in older HIV+ and HIV- men” Journal of Acquired Immune Deficiency Syndrome 2016 72(5):513-20. PMID: 27003493

Lekas HM, Alfandre DJ, Gordon P, Harwood HE, Yin MT. When patient-provider relationships collapse: using an accounts framework to explain hospital discharges Against Medical Advice. Social Science and Medicine 2016, 156:106-113. PMID: 27023920.

Young P, Shah J, Zhang C, Ferris DC, Colon I, Bucovsky M, Punyanitiya M, McMahon DJ, Shane E, Yin MT. Frailty in postmenopausal African American and Hispanic HIV-infected women, Journal of Frailty and Aging 2016; 5(4):242-246. PMID: 27883171

Cortes YI, Reame N, Zeana C, Jia H, Ferris DC, Shane E, Yin MT. Cardiovascular risk in HIV infected and uninfected postmenopausal minority women: use of the Framingham risk score. Journal of Women’s Health 2016, 26(3):241-248. PMID: 227611626

Arpadi S, Shiau S, Strehlau R, Pinillos F, Patel F, Kuhn L, Coovadia A, Ramteke S, Kaufman JL, Yin MT. Efavirenz is associated with higher bone mass in South African children with HIV. AIDS 2016, 30(16): 2459-2467. PMID: 27427876. PMCID:PMC5069169

Wadhwa S, Kim GJ, Reiss S, Finkel A, Yin MT. Increased alveolar crestal bone loss in older HIV-infected women. New York State Dental Journal 2017, 83(5): 22-28.

Ramteke SM, Kaufman JJ, Arpadi SM, Shiau S, Strehlau R, Patel F, Mbete N, Coovadia A, Yin MT. Unusually high calcaneal speed of sound measurements in children with small foot size. Ultrasound in Medicine and Biology 2017, 13(1):357-361. PMID: 27692859

Yin MT, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne K, Napoli A, Hardin R, Ribaudo HJ, Overton ET. Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation: ACTG 5280. AIDS 2017, 31(17): 2337-2344. PMID 28832406

Sharma A, Hoover DR, Shi Q, Holman S, Plankey MW, Tien PC, Weber KM, Floris-Moore M, Bolivar HH, Vance DE, Golub ET, Holstad MM, Yin MT. Falls among HIV-infected and Uninfected Women: the Role of Cognition. Antiviral Therapy 2017 Sept 21. PMIC 28933703.

Alfandre DJ, Harwood KE, Yang J, Lekas HM, Gordon P, Yin MT. “Against Medical Advice" Discharges Among HIV-Infected Patients - Health and Health Services Outcomes .” Journal of the Association of Nurses in AIDS Care 2017 (1): 96-94 PMID: 27815018

Kubin C, Nelson B, Miglis C, Scheetz M, Rhodes N, Avedissian S, Cremers S, Yin MT. Population pharmacokinetics of intravenous polymyxin B from clinical samples. Antimicrobial Agents and Chemotherapy 2018 [Epub ahead of print] PMID: 29311066

Yin MT, RoyChoudhury A, Nishiyama K, Lang T, Shah J, Olender S, Ferris DC, Zeana C, Sharma A, Zingman B, Bucovsky M, Colon I, Shane E. Bone density and microarchitecture in Hepatitis C and HIV coinfected postmenopausal minority women, Osteoporosis International 2018, 29(4): 871-79. PMID 29387910

Yang J, Sharma A, Shi Q, Anastos K, Cohen MH, Golub ET, Gustafson D, Merenstein D, Mack WJ, Tien PC, Nieves J, Yin MT. Improved fracture prediction using different FRAX adjustments in HIV-infected women. AIDS 2018 Epub ahead of print] PMID:29762165.